You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 290 No. 17, November 5, 2003 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (5)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Genetic Disorders
 •Women's Health, Other
 •Cardiovascular Disease/ Myocardial Infarction
 •Alert me on articles by topic

Estrogen Receptor 1 Variants and Coronary Artery Disease

Shedding Light Into a Murky Pool

Paul N. Hopkins, MD, MSPH; Eliot A. Brinton, MD

JAMA. 2003;290:2317-2319.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The article by Shearman et al1 in this issue of THE JOURNAL brings intriguing genetic data to bear on several issues of considerable current controversy—the relationship between coronary artery disease (CAD) and estrogen action, the general utility of CAD associations with variants in candidate genes, and the challenges of identifying causative gene variants for common disease. In this interesting hybrid of a case-control and prospective design, the investigators extracted DNA from blood samples of a subset of unrelated members of the Framingham offspring cohort who were alive at examination 6 (approximately 27 years after the baseline examination). The subset was selected to achieve an approximately equal number of representative men and women from the cohort. The effects of several estrogen receptor {alpha} (ESR1) gene variants were tested using primarily a case-control analysis in which offspring who had developed atherosclerotic disease . . . [Full Text of this Article]

Author Affiliations: Department of Cardiovascular Genetics, University of Utah, Salt Lake City).


RELATED ARTICLE

Association Between Estrogen Receptor {alpha} Gene Variation and Cardiovascular Disease
Amanda M. Shearman, L. Adrienne Cupples, Serkalem Demissie, Inga Peter, Christopher H. Schmid, Richard H. Karas, Michael E. Mendelsohn, David E. Housman, and Daniel Levy
JAMA. 2003;290(17):2263-2270.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Low Serum Testosterone and High Serum Estradiol Associate With Lower Extremity Peripheral Arterial Disease in Elderly Men: The MrOS Study in Sweden
Tivesten et al.
J Am Coll Cardiol 2007;50:1070-1076.
ABSTRACT | FULL TEXT  

Circulating Estradiol Is an Independent Predictor of Progression of Carotid Artery Intima-Media Thickness in Middle-Aged Men
Tivesten et al.
J. Clin. Endocrinol. Metab. 2006;91:4433-4437.
ABSTRACT | FULL TEXT  

Sex Differences and Genetic Associations With Myocardial Infarction
Newton-Cheh and O'Donnell
JAMA 2004;291:3008-3010.
FULL TEXT  

Estrogen-Receptor Gene Variant Linked with Increased CVD Risk
Journal Watch Cardiology 2004;2004:2-2.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.